[go: up one dir, main page]

AU3591697A - Method for the treatment of preterm labor - Google Patents

Method for the treatment of preterm labor

Info

Publication number
AU3591697A
AU3591697A AU35916/97A AU3591697A AU3591697A AU 3591697 A AU3591697 A AU 3591697A AU 35916/97 A AU35916/97 A AU 35916/97A AU 3591697 A AU3591697 A AU 3591697A AU 3591697 A AU3591697 A AU 3591697A
Authority
AU
Australia
Prior art keywords
treatment
preterm labor
preterm
labor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU35916/97A
Inventor
Joseph J Salata
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9701281.9A external-priority patent/GB9701281D0/en
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of AU3591697A publication Critical patent/AU3591697A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
    • C07D243/24—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU35916/97A 1996-07-02 1997-06-27 Method for the treatment of preterm labor Abandoned AU3591697A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US2113896P 1996-07-02 1996-07-02
US60021138 1996-07-02
GB9701281 1997-01-22
GBGB9701281.9A GB9701281D0 (en) 1997-01-22 1997-01-22 Method for the treatment of preterm labor
PCT/US1997/011608 WO1998000406A1 (en) 1996-07-02 1997-06-27 Method for the treatment of preterm labor

Publications (1)

Publication Number Publication Date
AU3591697A true AU3591697A (en) 1998-01-21

Family

ID=26310843

Family Applications (1)

Application Number Title Priority Date Filing Date
AU35916/97A Abandoned AU3591697A (en) 1996-07-02 1997-06-27 Method for the treatment of preterm labor

Country Status (2)

Country Link
AU (1) AU3591697A (en)
WO (1) WO1998000406A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6352982B1 (en) 1997-04-21 2002-03-05 Takeda Chemical Industries, Ltd. 4,1-benzoxazepines, their analogues, and their use as somatostatin agonists
NZ538870A (en) 2002-09-20 2007-04-27 Arrow Therapeutics Ltd Benzodiazepine derivatives and pharmaceutical compositions containing them

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4663321A (en) * 1984-06-26 1987-05-05 Merck & Co., Inc. Triazolobenzodiazepines and pharmaceutical use
US4628084A (en) * 1986-01-02 1986-12-09 Merck & Co., Inc. Process for 3-acylamino benzodiazepines
US4970207A (en) * 1988-07-07 1990-11-13 Fujisawa Pharmaceutical Company, Ltd. Benzodiazepine derivatives
DK0411668T4 (en) * 1989-08-04 1999-08-09 Merck Sharp & Dohme Central cholecystokinin antagonists for the treatment of mental disorders
US5175159A (en) * 1989-10-05 1992-12-29 Merck & Co., Inc. 3-substituted-1,4-benzodiazepines as oxytocin antagonists
US5324726A (en) * 1989-12-18 1994-06-28 Merck & Co., Inc. Benzodiazepine analogs
GB9015879D0 (en) * 1990-07-19 1990-09-05 Fujisawa Pharmaceutical Co Benzodiazepine derivatives
US5220017A (en) * 1991-04-10 1993-06-15 Merck & Co., Inc. Cholecystokinin antagonists
AU667690B2 (en) * 1991-10-24 1996-04-04 Merck Sharp & Dohme Limited Benzodiazepine derivatives and their use as antagonists of cholecystokinin and/or gastrin receptors
AU2759692A (en) * 1991-10-24 1993-05-21 Glaxo Group Limited Benzodiazepine derivatives as antagonists of gastrin and/or cholecystokinin
US5428031A (en) * 1991-12-03 1995-06-27 Merck & Co., Inc. Methods of treating cardiac arrhythmia
GB9209518D0 (en) * 1992-05-01 1992-06-17 Merck Sharp & Dohme Therapeutic agents
US5360802A (en) * 1992-05-11 1994-11-01 Merck Sharpe & Dohme Ltd. Benzodiazepine derivatives, compositions containing them and their use in therapy
US5618812A (en) * 1992-07-29 1997-04-08 Merck Sharp & Dohme, Ltd. Benzodiazepine derivatives
WO1994003447A1 (en) * 1992-07-29 1994-02-17 Merck Sharp & Dohme Limited Benzodiazepine derivatives
US5324483B1 (en) * 1992-10-08 1996-09-24 Warner Lambert Co Apparatus for multiple simultaneous synthesis
JP3257731B2 (en) * 1993-09-29 2002-02-18 塩野義製薬株式会社 Benzodiazepine derivatives with anti-ulcer activity
US5438055A (en) * 1993-11-22 1995-08-01 Merck & Co., Inc. Antiarrhythmic benzodiazepines
US5426185A (en) * 1993-11-22 1995-06-20 Merck & Co., Inc. Antiarrhythmic benzodiazepines
US5753650A (en) * 1994-05-20 1998-05-19 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
JP2000504306A (en) * 1994-08-18 2000-04-11 メルク エンド カンパニー インコーポレーテッド N-2,3-dihydro-1- (2-propyl) -2-oxo-5-phenyl-1H-1,4-benzodiazepine
JPH10511928A (en) * 1994-10-14 1998-11-17 グラクソ、ウェルカム、ソシエタ、ペル、アツィオーニ Use of a CCK-B receptor antagonist for the treatment of sleep disorders
US5556969A (en) * 1994-12-07 1996-09-17 Merck Sharp & Dohme Ltd. Benzodiazepine derivatives

Also Published As

Publication number Publication date
WO1998000406A1 (en) 1998-01-08

Similar Documents

Publication Publication Date Title
AU4838097A (en) Apparatus for the treatment of specimens
AU2543097A (en) Method for treating pain
AU2587297A (en) Method for treating pain
AU3441197A (en) 3-ureido-pyridofurans and -pyridothiophenes for the treatment of inflammatory processes
AU3190097A (en) Desalination apparatus and method of operating the same
GB9617780D0 (en) Method of treatment
AU3825097A (en) Method for tightening skin
IL129759A0 (en) Process for the preparation of benzyl-ethers
AU1572897A (en) Apparatus and method for the diagnosis of true labor
AU4248597A (en) Methods and compositions for treating preterm labor
AU1865497A (en) Method for the treatment of a liquid
AU2340897A (en) Method for treating pain
IL119612A0 (en) Method for the production of khalas
AU3783097A (en) Process for the preparation of hexanitrohexaazaisowurtzitanes
HUP9901029A3 (en) Method for the production of rdspa alfa1
AU4027097A (en) Method of treatment
GR3035436T3 (en) Process for the preparation of 2-H-heptafluoropropane
ZA973988B (en) Method of treatment
AU3591697A (en) Method for the treatment of preterm labor
EP0816318A3 (en) Method for the preparation of 4-hydroxybiphenyl
EP0831156A4 (en) Process for the preparation of 3-alkoxymethylcephems
AU3989995A (en) Method of treating membranes
AU1207497A (en) Process for the preparation of para-fluorophenol
AU4202697A (en) Method for the production of lactams
HUP9904497A3 (en) Method for the production of ivermectin